Skip to main content
Caplight Logo









Newsoara Biopharma Co., Ltd.

Newsoara Biopharma Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://newsoara.com/

Company Overview

Newsoara Biopharma Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. It was founded in 2018.

Newsoara Biopharma Co., Ltd. is a biotechnology company that develops biomedical solutions and products for hospitals and medical institutions, with a focus on novel drug research and discovery in oncology, autoimmune, respiratory, and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Newsoara Biopharma Co., Ltd. Comparables

Compare Newsoara Biopharma Co., Ltd. with similar companies based on industry and business-model similarity.

Newsoara Biopharma Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zenith Capital Corp.
78%
Zai Lab Limited
73%
Genelux Corporation
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Newsoara Biopharma Co., Ltd. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Newsoara Biopharma Co., Ltd.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Newsoara Biopharma Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Newsoara Biopharma Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Newsoara Biopharma Co., Ltd.'s valuation, stock price, and market status.

Is Newsoara Biopharma Co., Ltd. a public or private company?

Newsoara Biopharma Co., Ltd. is a private company.

What is the current stock price of Newsoara Biopharma Co., Ltd.?

Newsoara Biopharma Co., Ltd. is a private company with no public stock price. Caplight tracks Newsoara Biopharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Newsoara Biopharma Co., Ltd. worth (valuation)?

Valuation information for Newsoara Biopharma Co., Ltd. is not publicly available.

Can I buy Newsoara Biopharma Co., Ltd. stock?

Newsoara Biopharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Newsoara Biopharma Co., Ltd.'s last funding round?

Funding round information for Newsoara Biopharma Co., Ltd. is not publicly available.

Who are the main investors in Newsoara Biopharma Co., Ltd.?

Investor information for Newsoara Biopharma Co., Ltd. is not publicly disclosed.

Will Newsoara Biopharma Co., Ltd. IPO soon?

No public IPO plans have been announced for Newsoara Biopharma Co., Ltd..

How can I track Newsoara Biopharma Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Newsoara Biopharma Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?